MedPath

The Prevalence of Lower Urinary Tract Symptoms (LUTS) in Poland

Completed
Conditions
To Evaluate Lower Urinary Tract Symptoms (LUTS) in Poland
Registration Number
NCT04121936
Lead Sponsor
Jagiellonian University
Brief Summary

The first large population-based study to evaluate lower urinary tract symptoms (LUTS) in Poland. The study objective is to assess the prevalence and bother of LUTS in the population aged ≥40 years in Poland.

Detailed Description

The first large population-based study to evaluate lower urinary tract symptoms (LUTS) in Poland. The study objective is to assess the prevalence and bother of LUTS in the population aged ≥40 years in Poland.

This study will be conducted as a telephone survey with assessment of LUTS using a standardized protocol, which included the International Prostate Symptom Score (IPSS) and, for overactive bladder (OAB), the OAB-V8 questionnaire. Participants will be asked to rate how often they experienced individual LUTS and the degree of associated bother.

The study will be performed in a representative group of Polish population (n = 6,000) covering all geographic regions of Poland (defined by the Central Statistical Office of Poland).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6000
Inclusion Criteria

Age >40

Exclusion Criteria

Age <40 Pregnancy Urinary tract infection in the past 4 weeks

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of LUTSThrough study completion, an average of 3 months

The prevalence of LUTS will be assessed using definitions of the International Continence Society (descriptive statistics).

Symptom bother of LUTSThrough study completion, an average of 3 months

The degree of associated bother will be assessed using Likert scale (Likert scale: not at all \[score 0\], a little bit \[score 1\], somewhat \[score 2\], quite a bit \[score 3\], a great deal \[score 4\], or a very great deal \[score 5\]).

Secondary Outcome Measures
NameTimeMethod
Symptom bother of specific symptomsThrough study completion, an average of 3 months

The degree of associated bother of specific symptoms will be assessed using Likert scale (Likert scale: not at all \[score 0\], a little bit \[score 1\], somewhat \[score 2\], quite a bit \[score 3\], a great deal \[score 4\], or a very great deal \[score 5\]).

Prevalence of specific symptomsThrough study completion, an average of 3 months

The prevalence of specific symptoms will be assessed using a standardised protocol based on the definitions provided by the International Continence Society (i.e. storage symptoms, voiding symptoms and post-micturition symptoms) \[Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167-178\]. Participants will be asked to rate how often they experienced individual LUTS during the past month. A Likert scale will be used with the following options: none (score 0), \<1 in 5 times (score 1), \<half the time (score 2), about half the time (score 3), \>half the time (score 4), or almost always (score 5).

Prevalence of OABThrough study completion, an average of 3 months

The prevalence of OAB will be assessed with the Overactive Bladder-Validated 8-question Screener (OAB-V8)questionnaire.

Trial Locations

Locations (1)

Department of Urology Jagiellonian University

🇵🇱

Krakow, Poland

© Copyright 2025. All Rights Reserved by MedPath